Learn More
Medchemexpress LLC ML-7 hydrochloride | 110448-33-4 | C15H18ClIN2O2S | 5 MG

Supplier: Medchemexpress LLC HY154175MG
ML-7 hydrochloride is a naphthalene sulphonamide derivative that potently inhibits Myosin Light Chain Kinase (MLCK) with an IC50 of 300 nM. It also acts as an inhibitor of YAP/TAZ. In vitro studies indicate its ability to inhibit rabbit portal vein α1-adrenoceptor NSCC and attenuate Dexmedetomidine (DMT)-induced contraction. In vivo, ML-7 hydrochloride has been shown to reduce brain edema formation after traumatic brain injury in mice.
- Inhibits Myosin Light Chain Kinase (MLCK)
- Acts as an inhibitor of YAP/TAZ
- Inhibits rabbit portal vein α1-adrenoceptor NSCC
- Attenuates Dexmedetomidine (DMT)-induced contraction
- Reduces brain edema formation after traumatic brain injury in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.